Crossmedika Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CROSSMEDIKA SA, and what generic and branded alternatives to CROSSMEDIKA SA drugs are available?
CROSSMEDIKA SA has four approved drugs.
Drugs and US Patents for Crossmedika Sa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crossmedika Sa | MEXILETINE HYDROCHLORIDE | mexiletine hydrochloride | CAPSULE;ORAL | 213500-002 | Jul 22, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Crossmedika Sa | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 209057-002 | Oct 31, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Crossmedika Sa | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 213503-001 | Jun 27, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Crossmedika Sa | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 209057-001 | Oct 31, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.